IRTC iRhythm Technologies Inc
Price (delayed)
$105.99
Market cap
$3.33B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$3.63
Enterprise value
$3.64B
iRhythm is a leading digital health care company redefining the way cardiac arrhythmias are clinically diagnosed. The company combines wearable biosensor devices worn for up to 14 days and cloud-based
Highlights
The company's net income rose by 25% QoQ and by 8% YoY
The EPS has increased by 25% from the previous quarter and by 10% YoY
IRTC's equity has dropped by 57% year-on-year but it is up by 27% since the previous quarter
The quick ratio has contracted by 6% from the previous quarter
Key stats
What are the main financial stats of IRTC
Market
Valuations
Earnings
Shares outstanding
31.41M
Market cap
$3.33B
Enterprise value
$3.64B
Price to earnings (P/E)
N/A
Price to book (P/B)
36.49
Price to sales (P/S)
5.59
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
6.15
Revenue
$591.84M
Gross profit
$407.53M
Operating income
-$115.51M
Net income
-$113.29M
EBIT
-$99.9M
EBITDA
-$74.13M
Free cash flow
-$30.55M
Per share
Balance sheet
Liquidity
EPS
-$3.63
EPS diluted
-$3.63
Free cash flow per share
-$0.98
Book value per share
$2.9
Revenue per share
$18.97
TBVPS
$29.83
Total assets
$931.45M
Total liabilities
$840.54M
Debt
$736.91M
Equity
$90.91M
Working capital
$534.9M
Debt to equity
8.11
Current ratio
5.82
Quick ratio
5.62
Net debt/EBITDA
-4.17
Margins
Efficiency
Dividend
EBITDA margin
-12.5%
Gross margin
68.9%
Net margin
-19.1%
Operating margin
-19.5%
Return on assets
-12.3%
Return on equity
-128.7%
Return on invested capital
-9.5%
Return on capital employed
-12.2%
Return on sales
-16.9%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
IRTC stock price
How has the iRhythm Technologies stock price performed over time
Intraday
1.15%
1 week
4.98%
1 month
-0.57%
1 year
-4.75%
YTD
17.54%
QTD
1.25%
Financial performance
How have iRhythm Technologies's revenue and profit performed over time
Revenue
$591.84M
Gross profit
$407.53M
Operating income
-$115.51M
Net income
-$113.29M
Gross margin
68.9%
Net margin
-19.1%
The net margin is up by 29% from the previous quarter and by 24% YoY
IRTC's operating margin is up by 28% from the previous quarter and by 23% YoY
The company's net income rose by 25% QoQ and by 8% YoY
The company's gross profit rose by 23% YoY and by 7% QoQ
Growth
What is iRhythm Technologies's growth rate over time
Valuation
What is iRhythm Technologies stock price valuation
P/E
N/A
P/B
36.49
P/S
5.59
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
6.15
The EPS has increased by 25% from the previous quarter and by 10% YoY
IRTC's P/B is 90% above its 5-year quarterly average of 19.0 and 5% above its last 4 quarters average of 34.2
IRTC's equity has dropped by 57% year-on-year but it is up by 27% since the previous quarter
The P/S is 46% below the 5-year quarterly average of 10.2
The revenue has grown by 20% YoY and by 6% from the previous quarter
Efficiency
How efficient is iRhythm Technologies business performance
iRhythm Technologies's ROE has plunged by 128% YoY
IRTC's return on invested capital has surged by 67% year-on-year and by 41% since the previous quarter
The ROA has soared by 57% YoY and by 35% from the previous quarter
The ROS has increased by 32% from the previous quarter and by 30% YoY
Dividends
What is IRTC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for IRTC.
Financial health
How did iRhythm Technologies financials performed over time
IRTC's total assets is 11% greater than its total liabilities
The current ratio has surged by 171% year-on-year but it has declined by 7% since the previous quarter
IRTC's total assets has surged by 115% year-on-year and by 2.4% since the previous quarter
IRTC's equity has dropped by 57% year-on-year but it is up by 27% since the previous quarter
The debt to equity has contracted by 21% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.